Clinical applications of ultra-high field magnetic resonance imaging in multiple sclerosis

References

• Compston A, Coles A. Multiple sclerosis. Lancet. 2008;372:1502–1517.
   PubMed Web of Science ®Google Scholar
• Lublin FD, Reingold SC, Ja C, et al. Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology. 2014;83:1–9.
   Web of Science ®Google Scholar
• Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2017;17:162–173.
   Web of Science ®Google Scholar
• Voelker R. Twice the power in new MRI. JAMA. 2017;318:2017.
   Web of Science ®Google Scholar
• Traboulsee AL, Simon J, Stone L, et al. Revised recommendations of the consortium of MS centers task force for a standardized MRI protocol and clinical guidelines for the diagnosis and follow-up of multiple sclerosis. AJNR Am J Neuroradiol. 2016;314:2034–2044.
   Google Scholar
• Á R, Wattjes MP, Tintoré M, et al. Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis – clinical implementation in the diagnostic process. Nat Rev Neurol. 2015;11:471–482.
   PubMed Web of Science ®Google Scholar
• Filippi M, Rocca MA, Ciccarelli O, et al. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15:292–303.
   PubMed Web of Science ®Google Scholar
• Duyn JH. The future of ultra-high field MRI and fMRI for study of the human brain. Neuroimage. 2012;62:1241–1248.
   PubMed Web of Science ®Google Scholar
• Tallantyre EC, Dixon JE, Donaldson I, et al. Ultra-high-field imaging distinguishes MS lesions from asymptomatic white matter lesions. Neurology. 2011;76:534–539.
   PubMed Web of Science ®Google Scholar
• Uǧurbil K, Adriany G, Andersen P, et al. Ultrahigh field magnetic resonance imaging and spectroscopy. Magn Reson Imaging. 2003;21:1263–1281.
   PubMedGoogle Scholar
• Trattnig S, Springer E, Bogner W, et al. Key clinical benefits of neuroimaging at 7T. Neuroimage. 2016;S1053-8119:30651–30656.
   Google Scholar
• Ge Y, Zohrabian VM, Grossman RI. Seven-tesla magnetic resonance imaging. JAMA Neurol. 2009;65:812–816.
   Google Scholar
• Tallantyre EC, Brookes M, Dixon J, et al. Demonstrating the perivascular distribution of MS lesions in vivo with 7-Tesla MRI. Neurology. 2008;70:2076–2078.
   PubMed Web of Science ®Google Scholar
• Fog T. On the vessel-plaque relationships in the brain in multiple sclerosis. Acta Neurol Scand. 1964;40:9–15.
   Web of Science ®Google Scholar
• Adams C, Poston R, Bulk S. Pathology, histochemistry and immunocytochemistry of lesions in acute multiple sclerosis. J Neurol Sci. 1989;92:291–306.
   PubMed Web of Science ®Google Scholar
• Tan IL, Van Schijndel RA, Pouwels PJW, et al. MR venography of multiple sclerosis. Am J Neuroradiol. 2000;21:1039–1042.
   PubMed Web of Science ®Google Scholar
• Kollia K, Maderwald S, Putzki N, et al. First clinical study on ultra-high-field MR imaging in patients with multiple sclerosis: comparison of 1.5T and 7T. Am J Neuroradiol. 2009;30:699–702.
   PubMed Web of Science ®Google Scholar
• Mistry N, Tallantyre EC, Dixon JE, et al. Focal multiple sclerosis lesions abound in “normal appearing white matter.”. Mult Scler J. 2011;17:1313–1323.
   PubMed Web of Science ®Google Scholar
• Marques JP, Kober T, Krueger G, et al. MP2RAGE, a self bias-field corrected sequence for improved segmentation and T1-mapping at high field. Neuroimage. 2010;49:1271–1281.
   PubMed Web of Science ®Google Scholar
• Polman CH, Reingold SC, Banwell B, et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292–302.
   PubMed Web of Science ®Google Scholar
• Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol. 2009;44:491–494.
   PubMed Web of Science ®Google Scholar
• Sati P, Oh J, Todd Constable R, et al. The central vein sign and its clinical evaluation for the diagnosis of multiple sclerosis: A consensus statement from the North American imaging in multiple sclerosis cooperative. Nat Rev Neurol. 2016;12:714–722.
   PubMed Web of Science ®Google Scholar
• Kangarlu A, Bourekas EC, Ray-Chaudhury A, et al. Cerebral cortical lesions in multiple sclerosis detected by MR imaging at 8 Tesla. AJNR Am J Neuroradiol. 2007 Feb;28(2):262–266.
   PubMed Web of Science ®Google Scholar
• Mainero C, Radding A. In vivo imaging of cortical pathology in multiple sclerosis using ultra-high field MRI. Neurology. 2009;941–948.
   PubMedGoogle Scholar
• Metcalf M, Xu D, Okuda DT, et al. High-resolution phased-array MRI of the human brain at 7 tesla: initial experience in multiple sclerosis patients. J Neuroimaging. 2010;20:141–147.
   PubMed Web of Science ®Google Scholar
• Tallantyre EC, Morgan PS, Dixon JE, et al. 3 Tesla and 7 Tesla MRI of multiple sclerosis cortical lesions. J Magn Reson Imaging. 2010;32:971–977.
   PubMed Web of Science ®Google Scholar
• Pitt D, Boster A, Pei W, et al. Imaging cortical lesions in multiple sclerosis with ultra–high-field magnetic resonance imaging. JAMA Neurol. 2015;67:812–818.
   Google Scholar
• Nielsen AS, Kinkel RP, Tinelli E, et al. Focal cortical lesion detection in multiple sclerosis: 3 tesla DIR versus 7 tesla FLASH-T2. J Magn Reson Imaging. 2012;35:537–542.
   PubMed Web of Science ®Google Scholar
• Yao B, Hametner S, Van Gelderen P, et al. 7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis. PLoS One. 2014;9:e108863.
   PubMed Web of Science ®Google Scholar
• Harrison DM, Oh J, Roy S, et al. Thalamic lesions in multiple sclerosis by 7T MRI: clinical implications and relationship to cortical pathology. Mult Scler. 2015;21:1139–1150.
   PubMed Web of Science ®Google Scholar
• Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain. 2005;128:2705–2712.
   PubMed Web of Science ®Google Scholar
• Kilsdonk ID, Jonkman LE, Klaver R, et al. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: a post-mortem verification study. Brain. 2016;139:1472–1481.
   PubMed Web of Science ®Google Scholar
• Dula AN, Pawate S, Dortch RD, et al. Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T. Mult Scler. 2017;22:320–328.
   Web of Science ®Google Scholar
• Hammond KE, Metcalf M, Carvajal L, et al. Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron. Ann Neurol. 2008;64:707–713.
   PubMed Web of Science ®Google Scholar
• Bagnato F, Hametner S, Yao B, et al. Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 Tesla. Brain. 2011;134:3599–3612.
   Web of Science ®Google Scholar
• Absinta M, Sati P, Schindler M, et al. Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest. 2016;126:2597–2609.
   PubMed Web of Science ®Google Scholar
• Cronin MJ, Wharton S, Al-Radaideh A, et al. A comparison of phase imaging and quantitative susceptibility mapping in the imaging of multiple sclerosis lesions at ultrahigh field. Magn Reson Mater Phys Biol Med. 2016;29:543–557.
   Google Scholar
• Wang Y, Spincemaille P, Liu Z, et al. Clinical quantitative susceptibility mapping (QSM): biometal imaging and its emerging roles in patient care. J Magn Reson Imaging. 2017;46:951–971.
   PubMed Web of Science ®Google Scholar
• Balchandani P, Naidich TP. Ultra-high-field MR neuroimaging. Am J Neuroradiol. 2015;36:1204–1215.
   PubMed Web of Science ®Google Scholar
• Craner MJ, Newcombe J, Black JA, et al. Molecular changes in neurons in multiple sclerosis: altered axonal expression of Na v 1. 2 and Na v 1. 6 sodium channels and Na+/Ca2+ exchanger. Pnas. 2004;101:8168–8173.
   PubMed Web of Science ®Google Scholar
• England JD, Gamboni F, Levinson SR. Increased numbers of sodium channels form along demyelinated axons. Brain Res. 1991;548:334–337.
   Google Scholar
• Waxman SG. Conduction in myelinated, unmyelinated, and demyelinated fibers. Arch Neurol. 1977;34:585–589.
   PubMed Web of Science ®Google Scholar
• Stys PK, Lesiuk H. Correlation between electrophysiological effects of mexiletine and ischemic protection in central nervous system white matter. Neuroscience. 1996;71:27–36.
   PubMed Web of Science ®Google Scholar
• Stys PK, Waxman SG, Ransom BR. Ionic mechanisms of anoxic injury in mammalian CNS white matter: role of Na+ channels and Na(+)-Ca2+ exchanger. J Neurosci. 1992;12:430–439.
   PubMed Web of Science ®Google Scholar
• Stys K, Ransom R, Tertiary WG. Quatemary local anesthetics protect CNS white matter from anoxic injury at concentrations that do not block excitability. J Neurophysiol 1992;67:1–5.
   Google Scholar
• Fern R, Ransom BR, Stys PK, et al. Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam. J Pharmacol Exp Ther. 1993;266:1549–1555.
   PubMed Web of Science ®Google Scholar
• Stys PK. Protective effects of antiarrhythmic agents against anoxic injury in eNS white matter. J Cereb Blood Flow Metab. 1995;15:425–432.
   PubMed Web of Science ®Google Scholar
• Bechtold DA, Kapoor R, Smith KJ. Axonal protection using flecainide in experimental autoimmune encephalomyelitis. Ann Neurol. 2004;55:607–616.
   PubMed Web of Science ®Google Scholar
• Lo AC, Saab CY. Black JA, et al. Phenytoin protects spinal cord axons and preserves axonal conduction and neurological function in a model of neuroinflammation in vivo. J. Neurophysiol. 2003;90:3566–3571.
   PubMed Web of Science ®Google Scholar
• Black JA, Liu S, Carrithers M, et al. Exacerbation of experimental autoimmune encephalomyelitis after withdrawal of phenytoin and carbamazepine. Ann Neurol. 2007;62:21–33.
   PubMed Web of Science ®Google Scholar
• Bechtold DA, Miller SJ, Dawson AC, et al. Axonal protection achieved in a model of multiple sclerosis using lamotrigine. J Neurol. 2006;253:1542–1551.
   PubMed Web of Science ®Google Scholar
• Al-Izki S, Pryce G, Hankey DJR, et al. Lesional-targeting of neuroprotection to the inflammatory penumbra in experimental multiple sclerosis. Brain. 2014;137:92–108.
   PubMed Web of Science ®Google Scholar
• Jain RK. Transport of molecules in the tumor interstitium: a review. Cancer Res. 1987;47:3039–3051.
   PubMed Web of Science ®Google Scholar
• Camero IL, Smith NKR, Pool TB, et al. Intracellular concentration of sodium and other elements as related to mitogenesis and oncogenesis in vivo. Cancer Res. 1980;40:1493–1500.
   PubMed Web of Science ®Google Scholar
• Nagy IZ, Lustyik G, Lukács G, et al. Correlation of malignancy with the intracellular Na+: K+ ratio in human thyroid tumors. Cancer Res. 1983;43:5395–5402.
   PubMed Web of Science ®Google Scholar
• Thulborn KR, Davis D, Snyder J, et al. Sodium MR imaging of acute and subacute stroke for assessment of tissue viability. Neuroimaging Clin N Am. 2005;15:639–653.
   PubMed Web of Science ®Google Scholar
• Maudsley AA, Hilal SK. Biological aspects of sodium-23 imaging. Br Med Bull. 1984;40:165–166.
   PubMed Web of Science ®Google Scholar
• Inglese M, Madelin G, Oesingmann N, et al. Brain tissue sodium concentration in multiple sclerosis: a sodium imaging study at 3 tesla. Brain. 2010;133:847–857.
   PubMed Web of Science ®Google Scholar
• Paling D, Solanky BS, Riemer F, et al. Sodium accumulation is associated with disability and a progressive course in multiple sclerosis. Brain. 2013;136:2305–2317.
   PubMed Web of Science ®Google Scholar
• Zaaraoui W, Konstandin S, Audoin B, et al. Distribution of brain sodium accumulation correlates with disability in multiple sclerosis. Radiology. 2012;264:859–867.
   PubMed Web of Science ®Google Scholar
• Maarouf A, Audoin B, Konstandin S, et al. Topography of brain sodium accumulation in progressive multiple sclerosis. Magma. 2014;27:53–62.
   PubMedGoogle Scholar
• Maarouf A, Audoin B, Pariollaud F, et al. Increased total sodium concentration in gray matter better explains cognition than atrophy in MS. Neurology. 2017;88:289–295.
   PubMed Web of Science ®Google Scholar
• Eisele P, Konstandin S, Szabo K, et al. Sodium MRI of T1 high signal intensity in the dentate nucleus due to gadolinium deposition in multiple sclerosis. J Neuroimaging. 2017;27:372–375.
   PubMed Web of Science ®Google Scholar
• Huhn K, Mennecke A, Linz P, et al. 23Na MRI reveals persistent sodium accumulation in tumefactive MS lesions. J Neurol Sci. 2017;379:163–166.
   PubMed Web of Science ®Google Scholar
• Fleysher L, Oesingmann N, Inglese M. B₀ inhomogeneity-insensitive triple-quantum-filtered sodium imaging using a 12-step phase-cycling scheme. NMR Biomed. 2010;23:1191–1198.
   PubMed Web of Science ®Google Scholar
• Fleysher L, Oesingmann N, Brown R, et al. Noninvasive quantification of intracellular sodium in human brain using ultrahigh-field MRI. NMR Biomed. 2013;26:9–19.
   PubMed Web of Science ®Google Scholar
• Petracca M, Vancea RO, Fleysher L, et al. Brain intra- and extracellular sodium concentration in multiple sclerosis: a 7 T MRI study. Brain. 2016;139:795–806.
   PubMedGoogle Scholar
• Nikić I, Merkler D, Sorbara C, et al. A reversible form of axon damage in experimental autoimmune encephalomyelitis and multiple sclerosis. Nat Med. 2011;17:495–499.
   PubMed Web of Science ®Google Scholar
• Zhang B, Seifert A, Kim J, et al. 7 Tesla 22-channel wrap-around coil array for cervical spinalcord and brainstem imaging. Mrm. 2017;78:1623–1634.
   PubMed Web of Science ®Google Scholar